Pemetrexed in combination with cisplatin in the first-line treatment of non-squamous NSCLC: Czech experience with 233 patients

• Authors: SKŘIČKOVÁ Jana; BORTLÍČEK Zbyněk; HEJDUK Karel; PEŠEK Miloš; KOLEK Vítězslav; ROUBEC Jaromír; TOMÍŠKOVÁ Marcela; ŠATÁNKOVÁ Monika; POVOLNÁ Zdenka; ČOUPKOVÁ Helena; SALAJKA František; SIXTOVÁ Dimka; KOUBKOVÁ Leona; HAVEL Libor; HRNCIARIK Michal; ZEMANOVÁ Milada; ČERNOVSKÁ Markéta
• Year of publication: 2013
• Type: Conference abstract
• MU Faculty or unit: Faculty of Medicine
• Description: In a group of 233 patients with advanced non-squamous NSCLC who were treated with pemetrexed in first line and in combination with cisplatin, the therapy was well tolerated: termination of treatment due to adverse events was reported only in 3.8% of patients. Median overall was 11.6 months, median progression-free survival was 4.2 months.